PGHL
NSEProcter & Gamble Health Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹6,287.00
80.00 (1.29%)
Medium VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹10.44K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
31.5
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹4,707+33.6%
52W High₹6,700-6.2%
Current Price
₹6,287.00
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹5,029.60
Upper Circuit₹7,544.40
Reference Price
₹6,287.00
Investment Checklist
Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹6730.5
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹5778.7
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
RSI at 74.7 — overbought, pullback risk
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
84%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
5935.08
EMA50
5570.51
EMA200
5531.1
Price Action
MIXED
NEUTRAL
Higher Highs6
Higher Lows5
Lower Highs3
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹6369.60
₹6603.80
₹6700.00
Support (Below)
₹6280.40
₹6079.40
₹5869.08
₹5684.60
₹5589.55
Volume Analysis
TrendDECREASING
Change-72.10%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹6224.13
3% Risk₹6098.39
5% Risk₹5972.65
7% Risk (Custom)
₹5846.91Technical Levels
1x ATR (Volatility)₹6116.21
2x ATR (Swing)₹5945.42
3x ATR (Trend)₹5774.63
Immediate Support₹6280.40
Moving Averages
EMA 9 (Short-term)₹6159.29
EMA 20 (Medium-term)₹5935.08
EMA 50 (Trend)₹5570.51
EMA 200 (Long-term)₹5531.10
Financials
Financial Analysis
| Metric | Sep '24 | Dec '24 | Mar '25 | Jun '25 |
|---|---|---|---|---|
| Revenue | ₹313.4 Cr | ₹309.8 Cr | ₹311 Cr | ₹338.7 Cr |
| Net Profit | ₹82.3 Cr | ₹90.9 Cr | ₹61.2 Cr | ₹66.2 Cr |
| EPS | ₹49.60 | ₹54.76 | ₹36.86 | ₹39.87 |
| Operating Profit | ₹117.3 Cr | ₹127.4 Cr | ₹84 Cr | ₹94.4 Cr |
ROE
37.34%
ROCE
50.03%
Debt/Equity
0.02
Current Ratio
2.39
OPM
27.86%
NPM
19.54%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 12 Feb 2026 | Interim Dividend - Rs 110 Per Share & Special Dividend Rs 50 Per Share | SPECIAL_DIVIDEND |
| 22 Aug 2025 | Dividend - Rs 45 Per Share | DIVIDEND |
| 21 Feb 2025 | Interim Dividend - Rs 80 Per Share | INTERIM_DIVIDEND |
| 28 Nov 2024 | Annual General Meeting/Dividend - Rs 60 Per Share | AGM |
| 14 Feb 2024 | Interim Dividend - Rs 50 Per Share & Special Dividend Rs 150 Per Share | SPECIAL_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for PGHL
View AllNEWS
positive
Business Standard - Markets 15d ago
Procter & Gamble Hygiene and Health Care standalone net profit declines 1.90% in the March 2026 quarter
Sales decline 5.20% to Rs 937.67 crore
AGARWALEYEAMRUTANJANMEDANTAMHHLPGHHPGHLZOTAFast Moving Consumer GoodsHealthcare
positive
LiveMint - Markets 16d ago
P&G Hygiene Q4 Results: Net profit remains flat at ₹156 crore; declares ₹60/share final dividend
In Q4FY26, Procter & Gamble Hygiene and Health Care's revenue fell 5% to ₹941.32 crore due to softer demand. However, FY26 saw revenue rise to ₹4,290.42 crore, with net profit increasing to ₹856.50 crore. Leadership changes were also announced.
AGARWALEYEAMRUTANJANDIVIDENDMEDANTAMHHLPGHHPGHLZOTAFast Moving Consumer GoodsFinancial Services
NEWS
positive
Business Standard - Markets 17d ago
P&G Health soars after Q4 PAT jumps 54.63% YoY
Procter & Gamble Health soared 12.17% to Rs 6,339.65 after the vitamins, minerals and supplements maker reported a strong set of Q4 FY26 earnings.
MEDANTAPGHHPGHLFast Moving Consumer GoodsHealthcare